updat forecast estim oct
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research oct
estim oct
price data
rate updat
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
star align perfectli intuit surgic
compani continu gain momentum gener surgeri
hernia colorect procedur enjoy robust growth
meanwhil matur procedur dvp dvh enjoy
unexpect renaiss larg due factor unlik repeat
total procedur growth highest level sinc
total volum half intuit perform
defi expect howev caution growth
like moder even compani continu discov
pocket opportun
consid long-term thesi compani particularli
conserv even compani procedur volum
exceed million think total address market sever
time size still offer compani ampl growth opportun
particularli oversea ultim ceil robot surgeri
virtual unlimit exist applic scratch
surfac possibl procedur could migrat robot
number categori still offer sizabl unpenetr
under-penetrated opportun outsid unit
state robot surgeri accept develop
world significantli lower absenc
formid competitor intuit surgic
continu domin robot surgeri arena
believ growth start deceler number
procedur penetr rate hit ceil area
dvp also believ compani increasingli run
manual laparoscopi viabl altern particularli
high-volum procedur appendectomi need
continu suppli practition tangibl evid
benefit robot surgeri clinic well econom
front compani
reli growth
intern seen skeptic past
said believ intuit competit posit remain superb
system sale probabl never reach growth rate
past compani still healthi growth profil
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
intuit surgic develop produc market robot system
assist minim invas surgeri also provid instrument
dispos accessori warranti servic system compani
place nearli da vinci system hospit world-wide
instal unit state grow number emerg
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
solid third quarter intuit rais fve
intuit surgic procedur growth third quarter
surpass alreadi strong perform first half
volum growth quarter allow firm boost
full-year guidanc adjust forecast
well think growth procedur drive
unpreced momentum continu
absenc macroeconom
moder factor result boost near-term
forecast instrument system servic
revenu expect larg unchang rais
fair valu estim per share consid
share current level expens retain wide
procedur growth unit state remark
outsid line
histor number driver growth remain
larg gener surgeri maintain torrid
adopt pace although cholecystectomi bump
unexpect matur gynecolog grew
quarter uncharacterist baffl
even compani believ gener surgeri
remain strong hernia colorect adopt
opportun still sizabl continu anticip
moder even possibl pullback matur
revenu grew quarter total unit
placement instal base impli
uptick util intuit continu see materi
growth trade-in quarter new
instal actual last year trade-in
oper leas account half total
placement suggest penetr rate final
start subsid system mix revers first
quarter xi model place result
asp jump million quarter
intuit margin came line forecast
research
develop sale spend effort ion
diagnost platform market three unit sold
quarter well sp roll-out outlook
margin remain steadi acceler
beyond ion adopt pick
rais fair valu estim per share
account higher-than-expect result
cash flow realiz sinc last updat forecast
system sale instrument servic revenu directli
tie procedur volum forecast intuit growth
compound annual growth rate driven
gener surgeri matur procedur deceler
compani strong perform gener surgeri
continu exceed forecast hernia particular
stay strong procedur surpass
dvh volum year gener surgeri
largest categori volum
total volum grow doubl digit averag
next decad also surpris
continu strength gynecolog urolog
still view sustain long term
deceler overal hysterectomi market like
continu per year chang
percept toward benign hysterectomi like
caus dvh struggl expand penetr rate beyond
current level project benign dvh volum
 grow singl digit throughout
averag high singl digit throughout
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
procedur main reason firm almost
alway command lofti valuat multipl bull
case expect firm total procedur volum grow
million would boost
revenu compound-annual-growth-rate teen forecast oper
margin grow minim compani maintain
price structur face competit fair valu
estim jump per share forecast bit
current trade level consid scenario
downsid could see downward pressur dvp
acceler dvh lose share laparoscopi
procedur fail make much ground procedur compound-annual-growth-rate
stay around system revenu declin part
owe competit pressur instrument servic
revenu rise midsingl digit margin also
pressur valuat drop per share
given wide rang outcom believ high
uncertainti rate appropri
expand instal base da vinci
system vast procedur databas think intuit
surgic dug wide moat around busi
system instrument price reflect firm monopoli
statu nich allow achiev
profit rare enjoy medic equip maker
adjust oper margin fact
gross margin intuit system compar
instrument consum compon profit
distinct industri consum typic
rare attract rapidli grow market
robot surgeri stay impenetr competit
long firm monopoli sooner later
ceas exist sever emerg competitor
expect growth rate system revenu becom
much less attract opinion vast major
instal platform easili absorb addit procedur
util rate go averag sell price
pressur forecast system sale low
singl digit instrument servic revenu expect
grow rapidli midsingl high singl digit
per year line procedur growth forecast
expect adjust oper margin stay well
entir forecast impli double-digit growth
oper incom period margin
expans trajectori slower intuit
abl deliv recent believ sever factor slow
expans
futur mix toward
lower-pr procedur roll lower-pr
platform carri lower margin eventu pressur
competit
virtual upsid limit valuat
compani fate tie size procedur market
abl penetr marketplac million
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
moat trend stabl stage game intuit
surgic meaning direct competitor
extend definit competit includ manual
laparoscopi intuit abil expand competit
unchalleng robot surgeri field
increasingli run manual surgeri particularli
ventur outsid core surgic area switch
cost anoth robot high hospit custom
term money train surgeon switch manual
lap done significantli less effort given
surgeon familiar mi forecast
procedur overal convert robot surgeri
next decad around procedur compound-annual-growth-rate
firm profit per procedur come
sever reason fewer greenfield opportun
 marketplac fulli satur lower averag sell
price dispos platform share
special challeng procedur sell cycl
intuit research develop product may also
start declin fewer procedur opportun
emerg innov cycl -- low-hang fruit
pick compani invest heavili
order penetr variou surgic special
outsid core market final see nois
competit front threat firm
moat might make certain procedur suscept
price pressur
none potenti significantli disrupt firm
oper erod return capit intuit
intellectu properti
system grow
instrument base sizabl barrier
ever-grow clinic databas present biggest
challeng new entrant amass bodi data
intuit possess new competitor convinc
enough hospit purchas trial instrument
extens period train robot-na da vinci-train
surgeon recruit will patient howev
certain compet instrument -- price attract
may make inroad procedures/speci current
under-penetrated intuit particularli hospit
balk da vinci cost
cost becom exorbit averag system price
around million repres larg portion typic
would need compel technolog price differ
switch machin wear natur
upgrad cycl around five eight year given need
purchas new instrument procedur instal
system provid rel depend stream
revenu per procedur long surgeon continu use
biggest threat intuit moat futur robot
surgeri gener plausibl cash-strap
hospit receiv addit reimburs robot
usag may opt plod yet cheaper altern
manual laparoscopi particularli clinic bodi work
support robot surgeri tradit mi lack
also plausibl robot surgeri may face applic
limit consid number variou
procedur alreadi perform da vinci seem
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
oth da vinci system assist multipl type
hospit drive procedur
intuit surgic potenti specialis rival
on-going high-margin instrument sale servic
revenu provid clinic case histori
sought surgeon hospit administr
ointuit surgic direct rival grow
base user build career
profici da vinci
owe may see emerg
competit particularli lower-cost procedur
oth firm averag utilis rate well
instal challeng hospit tri
maxim exist da vinci util
orobot gynaecolog slow probabl
continu declin forese futur along
hysterectomi gener owe gener
overus procedur
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
intuit balanc sheet spotless zero debt
ampl cash compani could arguabl leverag
balanc sheet strict cash deploy polici limit
usag tuck-in acquisit reinvest share
buyback compani resum buy-back polici recent
could acceler need balanc sheet health
concern extrem limit
one key long-term risk
competitor introduc compel altern da vinci
procedur siphon intuit growth
opportun potenti reduc profit
busi particularli curiou alphabet foray
robot surgeri via joint ventur johnson
johnson littl known respect industri giant
work interest field alon worth
monitor asid competit factor could
surgeri yet establish good altern
manual laparoscopi certain procedur benign
hysterectomi well gener surgeri reimburs
distinguish manual robot mi
robot instrument cost hospit forc
eat differ two procedur
clinic benefit well establish manual laparoscopi
outsid unit state cautiou adopt
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
intuit surgic superb record come
organ growth return capit technolog
revolutionari testament intuit
vision manag team abil drive
adopt expand area
superb applaud compani dedic
shield robust return capit avers expans
unrel area via acquisit appropri
share-buyback polici appear slow
compani share
stewardship rate exemplari
repres date owner name posit common share held report holder issuer
share
fund
share
fund
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
quarter xi model place result
asp jump million quarter
intuit margin came line forecast
research
develop sale spend effort ion
diagnost platform market three unit sold
quarter well sp roll-out outlook
margin remain steadi acceler
beyond ion adopt pick
solid third quarter intuit rais fve
intuit surgic procedur growth third quarter
surpass alreadi strong perform first half
volum growth quarter allow firm boost
full-year guidanc adjust forecast
well think growth procedur drive
unpreced momentum continu
absenc macroeconom
moder factor result boost near-term
forecast instrument system servic
revenu expect larg unchang rais
fair valu estim per share consid
share current level expens retain wide
procedur growth unit state remark
outsid line
histor number driver growth remain
larg gener surgeri maintain torrid
adopt pace although cholecystectomi bump
unexpect matur gynecolog grew
quarter uncharacterist baffl
even compani believ gener surgeri
remain strong hernia colorect adopt
opportun still sizabl continu anticip
moder even possibl pullback matur
revenu grew quarter total unit
placement instal base impli
uptick util intuit continu see materi
growth trade-in quarter new
instal actual last year trade-in
oper leas account half total
placement suggest penetr rate final
start subsid system mix revers first
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
